4
Changes in Ownership
abrdn Life Sciences Investors Filed Acc 0001510281-25-000174
10% owner sold 36,524 shares at an average $13.00 ($474,961)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Saba Capital Management, L.P. 10% owner | 2025-03-27 | Sale | −32,922 | $13.01 | $428,315 | 3,240,630 | I |
| Saba Capital Management, L.P. 10% owner | 2025-03-28 | Sale | −3,602 | $12.95 | $46,646 | 3,237,028 | I |
| Open-market sales · 36,524 sh · avg $13.00 · $474,961 | |||||||
Loading xslF345X05/primary_doc.xml…